![](/img/cover-not-exists.png)
Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
Huaiyu Yang, Sarah Chuzi, Lara Sinicropi-Yao, Dan Johnson, Ying Chen, Alisabet Clain, Lee Baer, Patrick J. McGrath, Jonathan W. Stewart, Maurizio Fava, George I. PapakostasVolume:
260
Language:
english
Pages:
6
DOI:
10.1007/s00406-009-0031-3
Date:
March, 2010
File:
PDF, 155 KB
english, 2010